CNTB
Connect Biopharma·NASDAQ
--
--(--)
--
--(--)
4.90 / 10
Netural
Fund flow metrics are favorable, scoring 7.05/10, with positive block, Large, and Extra-large inflows outweighing negative signals. However, analyst sentiment is unfavorable despite a strong consensus of Strong Buy (100% across two providers). Historical win rates vary widely, from 100% for BTIG to 0% for Lake Street, indicating unreliable predictive power. The current price trend is falling (-6.54%), and the composite analyst rating of 2.75 does not align with this decline, suggesting caution in relying on analyst views.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-13
InstitutionBTIG
Times predicted2
Historical Win Rate100.0%
What is the market sentiment for CNTB?
- CNTB holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.90/10 (Netural).
